Sacituzumab Govitecan in Primary HER2-negative Breast Cancer ~60 mi. (Fürstenwalde, Germany, +94 more cities) Schwerpunktpraxis der Gynäkologie und Onkologie HER2 Negative Breast Carcinoma sacituzumab govitecan chemotherapy, +1 more type
Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma ~61 mi. (Bad Saarow, Germany, +27 more cities) Helios Hospital Bad Saarow, Clinic for Hematology, Oncology and Palliative Medicine Dedifferentiated Liposarcoma milademetan targeted therapy
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer ~97 mi. (Szczecin, Poland, +228 more cities) Dom Lekarski S.A. /ID# 231479 MET Expression Non-Small Cell Lung Carcinoma telisotuzumab vedotin chemotherapy, +1 more type
Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations ~97 mi. (Berlin, Germany, +120 more cities) Charité - Universitatsmedizin Berlin FGFR3 A391E, +9 more biomarkers Urothelial Carcinoma infigratinib targeted therapy
Cancer Search
